Columbus Circle Investors’s Precigen PGEN Stock Holding History

Columbus Circle Investors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-73,657	Closed	-$2.04M	–	288
2016 Q3	$2.04M	Buy	73,657 +18,960	+35%	+$501K	0.02%	232
2016 Q2	$1.33M	Buy	+54,697	New	+$1.55M	0.01%	221
2014 Q2	–	Sell	-74,861	Closed	-$1.88M	–	297
2014 Q1	$1.88M	Buy	+74,861	New	+$2.07M	0.01%	256

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Columbus Circle Investors's PGEN Position: Q4 2016 in Review

Columbus Circle Investors sold out of Precigen (PGEN) in Q4 2016, closing a stake of 73,657 shares — an estimated $2.04M sold.

Columbus Circle Investors first reported a position in PGEN in Q1 2014 and held it in 3 quarters. The position peaked at $2.04M in Q3 2016. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

Columbus Circle Investors reported no remaining Precigen position as of Q4 2016 after selling out during the quarter.
Columbus Circle Investors sold 73,657 Precigen shares in Q4 2016, an estimated $2.04M.
Columbus Circle Investors first reported a position in Precigen in Q1 2014 and held it in 3 quarters.
Columbus Circle Investors's Precigen position peaked at $2.04M in Q3 2016.
171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Columbus Circle Investors's 13F filing for Q4 2016, filed 2 Feb 2017.